Valerio Alonzi
Grosseto, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Excessive Short-acting Beta-agonists Prescriptions in COPD Treated with Triple Inhaler Therapy: A Possible Marker of Frequent Exacerbations. A Retrospective Cohort Study.
Journal: Thoracic research and practice
Published: January 15, 2026
Real-Life Efficacy of Single-Inhaler Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate in Persistent COPD Users: A Retrospective Database Study.
Journal: Biomedicines
Published: August 07, 2025
Immunologic responses to antifibrotic treatment in IPF patients.
Journal: International immunopharmacology
Published: December 17, 2020
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis.
Journal: Panminerva medica
Published: December 04, 2020
Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study.
Journal: Frontiers in molecular biosciences
Published: July 09, 2020
Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review.
Journal: Biomarkers in medicine
Published: July 03, 2020
Serum KL-6 concentrations as a novel biomarker of severe COVID-19.
Journal: Journal of medical virology
Published: May 07, 2020
Serum KL-6 levels in pulmonary Langerhans' cell histiocytosis.
Journal: European journal of clinical investigation
Published: January 05, 2020
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features.
Journal: Internal and emergency medicine
Published: October 24, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026